These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 1664670)
1. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus. van Oirschot JT; Daus F; Kimman TG; van Zaane D Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670 [TBL] [Abstract][Full Text] [Related]
2. Latent infection and subsequent reactivation of pseudorabies virus in swine exposed to pseudorabies virus while nursing immune dams. Mengeling WL Am J Vet Res; 1989 Oct; 50(10):1658-66. PubMed ID: 2552871 [TBL] [Abstract][Full Text] [Related]
3. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs. Arellano PE; Morrison RB; Molitor TW; Thawley DG J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793 [TBL] [Abstract][Full Text] [Related]
4. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus. van Oirschot JT; Gielkens AL Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645 [TBL] [Abstract][Full Text] [Related]
5. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV. Kit S; Kit M; McConnell S; Lawhorn B Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426 [TBL] [Abstract][Full Text] [Related]
6. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure. Kelling CL; Staudinger WL; Rhodes MB Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139 [TBL] [Abstract][Full Text] [Related]
7. Evaluation in swine of a subunit vaccine against pseudorabies. Maes RK; Schutz JC Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337 [TBL] [Abstract][Full Text] [Related]
8. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus. McGregor S; Easterday BC; Kaplan AS; Ben-Porat T Am J Vet Res; 1985 Jul; 46(7):1494-7. PubMed ID: 2992326 [TBL] [Abstract][Full Text] [Related]
9. Transmission of two pseudorabies virus strains that differ in virulence and virus excretion in groups of vaccinated pigs. Bouma A; De Jong MC; Kimman TG Am J Vet Res; 1996 Jan; 57(1):43-7. PubMed ID: 8720236 [TBL] [Abstract][Full Text] [Related]
11. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs. van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659 [TBL] [Abstract][Full Text] [Related]
12. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E. Firkins LD; Weigel RM; Biehl LG; Hahn EC Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the pseudorabies virus-specific immunoglobulin M response and evaluation of its diagnostic use in pigs with preexisting immunity to the virus. Kimman TG J Clin Microbiol; 1993 Sep; 31(9):2309-14. PubMed ID: 8408547 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. Kimman TG; De Wind N; De Bruin T; de Visser Y; Voermans J Virology; 1994 Dec; 205(2):511-8. PubMed ID: 7975253 [TBL] [Abstract][Full Text] [Related]
15. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus. Kit S; Kit M; Pirtle EC Am J Vet Res; 1985 Jun; 46(6):1359-67. PubMed ID: 2992322 [TBL] [Abstract][Full Text] [Related]
16. Lack of serum antibodies against glycoprotein E in pseudorabies virus-immune pigs infected with wild-type virus. Jacobs L; Kimman TG; Bianchi A Am J Vet Res; 1996 Nov; 57(11):1525-8. PubMed ID: 8915423 [TBL] [Abstract][Full Text] [Related]
17. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I. van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288 [TBL] [Abstract][Full Text] [Related]
18. Protection against pseudorabies virus infection by intranasal vaccination of newborn pigs. McCaw MB; Xu J Am J Vet Res; 1993 Apr; 54(4):527-33. PubMed ID: 8387249 [TBL] [Abstract][Full Text] [Related]
19. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes. Marchioli CC; Yancey RJ; Wardley RC; Thomsen DR; Post LE Am J Vet Res; 1987 Nov; 48(11):1577-83. PubMed ID: 2829665 [TBL] [Abstract][Full Text] [Related]
20. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines. van Rooij EM; Moonen-Leusen HW; de Visser YE; Middel WG; Boersma WJ; Bianchi AT Vaccine; 2006 Feb; 24(9):1264-73. PubMed ID: 16289276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]